Your browser doesn't support javascript.
loading
Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma.
Yang, Guozhen; Su, Xiaodong; Yang, Hong; Luo, Guangyu; Gao, Chan; Zheng, Yating; Xie, Wenzhuan; Huang, Mengli; Bei, Ting; Bai, Yuezong; Wang, Zhiqiang; Cai, Peiqiang; He, Haoqiang; Xiang, Jin; Cai, Muyan; Zhang, Yijun; Qu, Chunhua; Fu, Jianhua; Liu, Qianwen; Hu, Yi; Zhong, Jiudi; Huang, Yuanheng; Guo, Qiyu; Zhang, Xu.
Afiliación
  • Yang G; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Su X; Guangdong Esophageal Cancer Institute, Guangzhou, China.
  • Yang H; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Luo G; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Gao C; Guangdong Esophageal Cancer Institute, Guangzhou, China.
  • Zheng Y; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Xie W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Huang M; Guangdong Esophageal Cancer Institute, Guangzhou, China.
  • Bei T; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Bai Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Wang Z; Department of Endoscopy, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Cai P; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • He H; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • Xiang J; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • Cai M; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • Zhang Y; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • Qu C; Medical Affairs, 3D Medicines, Inc., Shanghai, China.
  • Fu J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Liu Q; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Hu Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Zhong J; Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
  • Guo Q; Department of Medical Imaging and Interventional Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Zhang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
Ann Transl Med ; 9(15): 1254, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34532391
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Transl Med Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Ann Transl Med Año: 2021 Tipo del documento: Article País de afiliación: China